Sera Prognostics, Inc. announced the appointment of Mansoor Raza Mirza to its Board of Directors. Dr. Mirza is Chief Oncologist at the Department of Oncology, Rigshospitalet - the Copenhagen University Hospital, Denmark. He currently serves as a director of Karyopharm Therapeutics and Metamark Genetics.

Dr. Mirza chairs the Health Ministry's obligatory teaching course on non-surgical treatment of cancer for Danish doctors specializing in Clinical Oncology. He is vice-president of the Danish Gynecologic Cancer Group (DGCG) and medical director of Nordic Society of Gynecologic Oncology (NSGO).